_:vb748163 . _:vb748163 _:vb645785 . "anaplastic large cell lymphomaPTNCI-GLOSSCDR0000045552" . _:vb748162 _:vb748163 . _:vb748161 _:vb645783 . _:vb748159 _:vb748160 . _:vb748159 _:vb645781 . _:vb748162 _:vb645784 . "Anaplastic Large Cell LymphomaSYNCITCGA" . _:vb645785 . "ANAPLASTIC LARGE CELL LYMPHOMAPTFDA3264" . _:vb645784 . _:vb645784 . "ALCLSYFDA3264" . _:vb629593 . _:vb645785 . "C3720"^^ . _:vb645783 . "Ki-1+ ALCLSYNCI" . "Malignant"^^ . "Anaplastic Large Cell Lymphoma"^^ . "Anaplastic_Large_Cell_Lymphoma"^^ . _:vb645782 . "9714/3"^^ . "Ki-1+ Anaplastic Large Cell LymphomaSYNCI" . _:vb730232 _:vb748159 . "A peripheral (mature) T-cell lymphoma, consisting of usually large anaplastic, CD30 positive cells. The majority of cases are positive for the anaplastic large cell lymphoma (ALK) protein. The most frequently seen genetic alteration is a t(2;5) translocation. Majority of patients present with advanced disease. The most important prognostic indicator is ALK positivity, which has been associated with a favorable prognosis. (WHO, 2001)NCI" . . "ALCLPTNCI-GLOSSCDR0000575433" . "An aggressive (fast-growing) type of non-Hodgkin lymphoma that is usually of the T-cell type. The cancer cells express a marker called CD30 or Ki-1 on the surface, and may appear in the lymph nodes, skin, bones, soft tissues, lungs, or liver.NCI-GLOSS" . . _:vb645781 . "ALCLABNCI" . "CD30 Positive Anaplastic Large Cell LymphomaSYNCI" . _:vb730232 . _:vb645782 . _:vb629593 . _:vb645785 . _:vb645782 . _:vb645781 . _:vb629593 _:vb730457 . "Neoplastic Process"^^ . _:vb645783 . "C0206180"^^ . "Ki-1 LymphomaAQSNCI" . _:vb645784 . "Anaplastic Large Cell Lymphoma"^^ . . _:vb748161 _:vb748162 . "Anaplastic Large Cell LymphomaPTNCI" . _:vb748160 _:vb748161 . _:vb645783 . _:vb645781 . _:vb730457 . . "FDA"^^ . _:vb748160 _:vb645782 . _:vb730457 _:vb730232 .